Menu
In the 1970s, agrochemical company Monsanto developed one of the most potent chemical herbicides on the market: glyphosate. When the manufacturer began marketing the product as Roundup, it became one of the most popular herbicides in history, available for commercial and residential use.
But in 2015, the cancer research team at the World Health Organization classified glyphosate–Roundup’s active ingredient–as a probable human carcinogen. This means exposure to the chemical carries a risk of cancer. Scientists uncovered a specific link to non-Hodgkin’s lymphoma, which damages the body’s germ-fighting immune system.
Victims Come Forward
Since the WHO’s report on Roundup and glyphosate, thousands of cancer patients have come forward alleging that exposure to the chemical caused their illness. These victims rightfully demanded accountability and compensation from Bayer, which acquired Monsanto in 2018.
Bayer has already paid billions to plaintiffs, including a $10 billion settlement in 2020 that ended thousands of lawsuits. Before that, a jury awarded a California couple $2 billion. These are just a small sample of favorable outcomes for victims.
Roundup’s Entire Formula Under the Microscope
In 2021, Bayer announced it would remove glyphosate from its residential weed killer, effective January 2023.
In attempting to avoid accountability for their dangerous product, Bayer points to reports from the FDA and EPA that insist glyphosate is not harmful to humans. However, current and future litigation focuses on the dangers of Roundup’s entire formula–not just glyphosate.
Since 2016, Duncan|Stubbs has represented over 20,000 clients who allege their cancer diagnosis was caused by prolonged exposure to Roundup. Each and every case is handled and fought with the utmost care, led by some of the most respected and experienced lawyers in the field.
We understand that every story is different, and so a personalized legal strategy is key. There is no one-size-fits-all mentality at Duncan|Stubbs.
Finally, we have a proud reputation of refusing to back down until our clients receive maximum recoveries. Litigation will continue until we go to trial, or Bayer pays clients what they’re owed–no less.
Duncan|Stubbs Roundup lawsuits are pending around the country, and we are currently accepting new cases to ensure as many victims as possible receive compensation.
As always, Duncan|Stubbs charges nothing for its services unless a settlement is awarded.
January 2024:
A Philadelphia Common Pleas Court ordered Bayer to pay a staggering $2.25 billion to a man who was diagnosed with non-Hodgkin’s lymphoma after using Roundup weed killer in his yard for two decades. “The jury’s unanimous verdict was a condemnation of 50 years of misconduct by Monsanto and a declaration that its misconduct was in reckless disregard of human safety and a substantial cause of his cancer,” his attorneys said in a statement.
While these types of significant verdicts are outliers, they continue to increase pressure on Bayer/Monsanto to resolve their outstanding cases as quickly as possible.
November 2023:
A Missouri jury ordered Bayer to pay $1.56 billion to three Duncan Stubbs clients who claimed the company’s Roundup weedkiller caused their non-Hodgkin’s lymphoma. The jury found that Bayer’s Monsanto business was liable for claims of negligence, design defects and failing to warn plaintiffs of the potential dangers of using Roundup. Each plaintiff was diagnosed with non-Hodgkin’s lymphoma that they alleged was caused by using Roundup on their family property. This monumental verdict is also great news for you, as it strengthens our firm’s position to negotiate for the best possible compensation for all Duncan Stubbs clients.
October 2023:
Over the span of just 2 weeks, Bayer was dealt half a billion in verdict losses as courts sided with the people in 3 trials. A California jury awarded $332 million in damages after they found a man’s use of Roundup on his lawn for three decades led to his non-Hodgkin’s lymphoma diagnosis. A retired restaurant owner was awarded $175 million in Philadelphia after developing NHL after 20 years of Roundup use. And a St. Louis jury awarded a man who had been in remission from NHL for a decade $1.25 million after ruling Bayer failed to properly warm consumers of the potential risks of its weed killer.
Free Case Review
No fee unless you receive compensation.
"*" indicates required fields